Q2 2020 AcelRx Pharmaceuticals Inc Earnings Call
שיחת ועידה AcelRx Pharmaceuticals Inc
AcelRx Pharmaceuticals Inc Conference call or earnings call will be held on 10/08/2020 via an 800 number (toll-free). During the earnings conference call's session AcelRx Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact AcelRx Pharmaceuticals Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. Our lead product candidates, ARX-04 and Zalviso, utilize sublingual sufentanil, delivered via a non-invasive route of administration. We intend to commercialize our product candidates in the United States and license the development and commercialization rights to our product candidates for sale outside of the United States through strategic partnerships and collaborations. We may also consider the option to enter into strategic partnerships for our product candidates in the United States. We have chosen sufentanil as the therapeutic ingredient for all of our product candidates. Opioids have been utilized for pain relief for centuries and are the standard of care for the treatment of moderate-to-severe acute pain.קרא עוד שיחת ועידה